
    
      A Randomized, Double-Blind, Placebo-Controlled, Single-Center, Three-Way Cross-Over Study to
      Compare the Relative Efficacy of Budesonide administered via Captisol-Enabled® Budesonide
      Nasal Solution and Rhinocort Aqua® (32 µg/spray) in the Treatment of the Symptoms of Allergic
      Rhinitis in an Environmental Exposure Chamber (EEC).
    
  